Elective Nodal Irradiation for Locally Advanced Non-Small-Cell Lung Cancer: It's Called Cancer for a Reason

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 5, 2009, Pages 1291-1292

  Kelsey, Chris R ^a   Marks, Lawrence B ^b   Glatstein, Eli ^c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CLINICAL TRIAL; EDITORIAL; HUMAN; IRRADIATION; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; LYMPH NODE METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; TREATMENT FAILURE;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; LYMPHATIC IRRADIATION; LYMPHATIC METASTASIS; POSITRON-EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY;

EID: 62649127633     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.12.017     Document Type: Editorial

References (11)

1. Schild S.E. Elective nodal irradiation (ENI) doesn't appear to provide a clear benefit for patients with unresectable non-small-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 72 (2008) 311-312
2. Rosenzweig K.E., Sura S., Jackson A., et al. Involved-field radiation therapy for inoperable non small-cell lung cancer. J Clin Oncol 25 (2007) 5557-5561
3. Senan S., Burgers S., Samson M.J., et al. Can elective nodal irradiation be omitted in stage III non-small-cell lung cancer? Analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapy. Int J Radiat Oncol Biol Phys 54 (2002) 999-1006
4. Al-Sarraf N., Aziz R., Gately K., et al. Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography. Eur J Cardiothorac Surg 33 (2008) 104-109
5. Kim B.T., Lee K.S., Shim S.S., et al. Stage T1 non-small cell lung cancer: Preoperative mediastinal nodal staging with integrated FDG PET/CT-a prospective study. Radiology 241 (2006) 501-509
6. Videtic G.M., Rice T.W., Murthy S., et al. Utility of positron emission tomography compared with mediastinoscopy for delineating involved lymph nodes in stage III lung cancer: Insights for radiotherapy planning from a surgical cohort. Int J Radiat Oncol Biol Phys 72 (2008) 702-706
7. Lauer M.S., Murthy S.C., Blackstone E.H., et al. [18F]Fluorodeoxyglucose uptake by positron emission tomography for diagnosis of suspected lung cancer: Impact of verification bias. Arch Intern Med 167 (2007) 161-165
8. Yuan S., Sun X., Li M., et al. A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer. Am J Clin Oncol 30 (2007) 239-244
9. Hata E., Hayakawa K., Miyamoto H., et al. Rationale for extended lymphadenectomy for lung cancer. Theoretical Surgery 5 (1990) 19-25
10. Nohl-Oser H.C. An investigation of the anatomy of the lymphatic drainage of the lungs as shown by the lymphatic spread of bronchial carcinoma. Ann R Coll Surg Engl 51 (1972) 157-176
11. Kelsey C.R., Light K.L., and Marks L.B. Patterns of failure after resection of non-small-cell lung cancer: Implications for postoperative radiation therapy volumes. Int J Radiat Oncol Biol Phys 65 (2006) 1097-1105